|
VPS13B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.83759698965969E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.421300021067E-09 |
| Normal-vs-Stage2 |
3.73819999999192E-06 |
| Normal-vs-Stage3 |
1.60839996876661E-09 |
| Normal-vs-Stage4 |
1.36669999983852E-07 |
| Stage1-vs-Stage2 |
5.447600E-01 |
| Stage1-vs-Stage3 |
2.546400E-01 |
| Stage1-vs-Stage4 |
3.879600E-01 |
| Stage2-vs-Stage3 |
8.454400E-01 |
| Stage2-vs-Stage4 |
8.666600E-01 |
| Stage3-vs-Stage4 |
9.973200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.73460032396144E-10 |
| Normal-vs-AfricanAmerican |
3.244500E-03 |
| Normal-vs-Asian |
2.0275000000014E-06 |
| Caucasian-vs-AfricanAmerican |
3.573400E-01 |
| Caucasian-vs-Asian |
9.405800E-01 |
| AfricanAmerican-vs-Asian |
3.864400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.06346092727017E-12 |
| Normal-vs-Female |
2.96930002807727E-09 |
| Male-vs-Female |
7.059500E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.87689999495444E-08 |
| Normal-vs-Age(41-60Yrs) |
2.56940002607564E-09 |
| Normal-vs-Age(61-80Yrs) |
5.22069998343255E-09 |
| Normal-vs-Age(81-100Yrs) |
2.675700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.242200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.491400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.680400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.354600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.476200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.695400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.256000E-02 |
| Classical-VS-Follicular |
6.552800E-04 |
| Classical-VS-Other |
9.632400E-02 |
| Classical-VS-Normal |
6.99250000124607E-08 |
| Tall-VS-Follicular |
6.433000E-01 |
| Tall-VS-Other |
3.873200E-01 |
| Tall-VS-Normal |
9.85869999969857E-07 |
| Follicular-VS-Other |
6.057600E-01 |
| Follicular-VS-Normal |
8.6093021600675E-11 |
| Other-VS-Normal |
8.374800E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.04560035577117E-10 |
| Normal-vs-N1 |
2.23899999984845E-07 |
| N0-vs-N1 |
7.308400E-01 |
|
|
